Table 2.
Raw Means and Standard Deviations of Self-Report Measures at Baseline and Follow-Up Time Points
| Baseline |
Last Week of Treatment |
1 Month Post-Treatment |
3 Months Post-Treatment |
6 Months Post-Treatment |
|||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YG |
ST |
WL |
P | YG |
ST |
WL |
P | YG |
ST |
WL |
P | YG |
ST |
WL |
P | YG |
ST |
WL |
P | ||||||||||||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | ||||||
| PCS | 41.8 | 1.3 | 43.0 | 1.1 | 44.9 | 1.4 | .20 | 42.3 | 1.3 | 44.5 | 1.1 | 44.1 | 1.2 | .47 | 47.0* | 1.3 | 46.8 | 1.4 | 45.5 | 1.2 | .04 | 48.2* | 1.2 | 47.4 | 1.4 | 46.1 | 1.2 | .05 | 46.9 | 1.4 | 47.5 | 1.4 | 46.6 | 1.1 | .18 |
| PF | 41.9 | 1.3 | 44.7 | 1.2 | 45.9 | 1.2 | .06 | 43.7 | 1.4 | 46.0 | 1.1 | 45.7 | 1.3 | .18 | 47.3*† | 1.3 | 46.6 | 1.3 | 47.0 | 1.1 | .005 | 48.7*† | 1.1 | 47.2‡ | 1.2 | 46.3 | 1.4 | .0001 | 47.8* | 1.4 | 47.4 | 1.4 | 46.5 | 1.2 | .005 |
| GH | 44.8 | 1.5 | 50.4 | 1.2 | 47.7 | 1.2 | .01 | 47.1 | 1.4 | 50.6 | 1.1 | 48.0 | 1.3 | .28 | 47.9*† | 1.5 | 49.2 | 1.4 | 46.9 | 1.5 | .003 | 49.2*† | 1.4 | 50.5 | 1.3 | 46.3 | 1.5 | .005 | 47.7 | 1.6 | 51.7 | 1.3 | 49.8 | 1.1 | .35 |
| RF | 36.8 | 1.5 | 37.1 | 1.3 | 38.3 | 1.6 | .70 | 39.1 | 1.4 | 41.1 | 1.4 | 40.8 | 1.5 | .54 | 44.2 | 1.5 | 43.8 | 1.7 | 43.5 | 1.5 | .50 | 45.0 | 1.6 | 45.5 | 1.7 | 44.3 | 1.4 | .66 | 44.3 | 1.6 | 46.4 | 1.5 | 44.1 | 1.3 | .28 |
| BP | 44.2 | 1.4 | 44.8 | 1.2 | 44.6 | 1.5 | 1.00 | 44.3 | 1.3 | 46.4 | 1.3 | 45.1 | 1.4 | .67 | 47.5 | 1.5 | 48.3 | 1.6 | 48.4 | 1.4 | .98 | 49.0 | 1.4 | 48.9 | 1.5 | 47.5 | 1.5 | .84 | 46.8 | 1.5 | 48.3 | 1.4 | 48.3 | 1.3 | .81 |
| MCS | 42.2 | 1.7 | 45.8 | 1.4 | 42.0 | 1.8 | .20 | 47.2 | 1.9 | 49.5 | 1.2 | 47.1 | 1.7 | .88 | 46.2 | 2.1 | 47.0 | 1.7 | 49.1 | 1.5 | .07 | 46.5 | 2.0 | 50.1 | 1.6 | 46.6 | 1.9 | .80 | 46.8 | 1.9 | 50.8 | 1.5 | 48.8 | 1.4 | .75 |
| CES-D | 15.4 | 1.5 | 11.7 | 0.8 | 15.1 | 1.4 | .07 | 17.3 | 1.4 | 17.8 | 1.1 | 15.8 | 1.4 | .53 | 13.1 | 1.7 | 11.6 | 1.4 | 12.3 | 1.3 | .19 | 13.9 | 1.7 | 9.6 | 1.4 | 12.9 | 1.6 | .68 | 13.9 | 1.8 | 10.4 | 1.4 | 11.5 | 1.3 | .23 |
| PSQI | 8.3 | 0.6 | 8.5 | 0.5 | 8.2 | 0.5 | .90 | 6.7 | 0.5 | 8.3 | 0.6 | 7.3 | 0.5 | .60 | 7.0 | 0.6 | 7.7 | 0.7 | 5.8 | 0.6 | .40 | 6.5 | 0.5 | 7.3 | 0.5 | 6.4 | 0.6 | .5 | 7.1 | 0.5 | 7.2 | 0.6 | 6.4 | 0.6 | 1.00 |
| BFI | 3.2 | 0.3 | 3.0 | 0.3 | 2.6 | 0.3 | .30 | 2.9* | 0.3 | 2.5‡ | 0.3 | 3.2 | 0.4 | .03 | 2.7 | 0.4 | 2.7 | 0.3 | 2.7 | 0.3 | .22 | 2.6 | 0.3 | 2.3 | 0.4 | 3.0 | 0.4 | .15 | 2.8 | 0.4 | 2.5 | 0.3 | 2.6 | 0.3 | .56 |
NOTE. The baseline P values are from analysis of variance of raw scores. The follow-up P values represent the group main effects from the MIXED models analyses of change scores and the noted group differences are from the same MIXED models. Significant group differences are labeled below.
Abbreviations: BFI, Brief Fatigue Inventory; BP, Medical Outcomes Study 36-Item Short-Form Survey (SF-36) Bodily Pain; CES-D, Center for Epidemiologic Studies-Depression; GH, SF-36 General Health; MCS, SF-36 Mental Component Score; PCS, SF-36 Physical Component Score; PF, SF-36 Physical Functioning; PSQI, Pittsburg Sleep Quality Index; RP, SF-36 Role-physical; ST, stretching; WL, waitlist; YG, yoga.
YG versus WL, P ≤ .05.
YG versus ST, P ≤ .05.
ST versus WL, P ≤ .05.